Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-Day and 12-month clinical and echocardiographic outcomes from the GRASP (getting reduction of mitral insufficiency by percutaneous clip implantation) registry

JACC: Cardiovascular Interventions

Volumn 8, Issue 1, 2015, Pages 74-82

  Attizzani, Guilherme F ^a,b,c   Ohno, Yohei ^a,d   Capodanno, Davide ^a,d,e   Cannata, Stefano ^a   Dipasqua, Fabio ^a   Immé, Sebastiano ^a   Mangiafico, Sarah ^a   Barbanti, Marco ^a   Ministeri, Margherita ^a   Cageggi, Anna ^a   Pistritto, Anna Maria ^a   Giaquinta, Sandra ^a   Farruggio, Silvia ^a   Chiarandà, Marta ^a   Ronsivalle, Giuseppe ^a   Schnell, Audrey ^b   Scandura, Salvatore ^a   Tamburino, Corrado ^a,d,e   Capranzano, Piera ^a   Grasso, Carmelo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Hospital Pitangueiras   (Brazil)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Excellence Through Newest Advances ETNA Foundation   (Italy)

Author keywords

Edge to edge mitral valve repair; EVEREST; GRASP; MitraClip; Mitral regurgitation; Percutaneous mitral valve repair

Indexed keywords

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HIGH RISK PATIENT; HUMAN; IMPLANT REGISTRY; IMPLANTABLE CLIP; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; ADVERSE EFFECTS; CASE CONTROL STUDY; CONVALESCENCE; DEVICES; ECHOGRAPHY; FEASIBILITY STUDY; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEMODYNAMICS; KAPLAN MEIER METHOD; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; FEASIBILITY STUDIES; FEMALE; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84921436903     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.07.024     Document Type: Article

References (24)

1. Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine potential role of MitraClip for this unmet need. J Am Coll Cardiol 2014;63:185-6.
2. Vahanian A, Alfieri O, Andreotti F, et al., for the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology and the European Association for Cardio- Thoracic Surgery. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96.
3. Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-201.
4. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004;77: 1966-77.
5. Andalib A,Mamane S, Schiller I, et al.Asystematic review and meta-analysis of surgical outcomes following mitral valve surgery in octogenarians: implications for transcatheter mitral valve interventions. EuroIntervention 2014;9:1225-34.
6. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol 2008;52:319-26.
7. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
8. Feldman T, Foster E, Glower DD, et al., for the EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
9. Grasso C, Capodanno D, Scandura S, et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol 2013;111:1482-7.
10. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESSEU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 2013;62:1052-61.
11. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
12. Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the Mitra- Clip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.
13. Mauri L, Foster E, Glower DD, et al., for the EVEREST II Investigators. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 2013;62:317-28.
14. Whitlow PL, Feldman T, Pedersen WR, et al., for the EVEREST II Investigators. Acute and 12- month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012;59:130-9.
15. Sürder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 2013;99:1034-40.
16. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
17. Schillinger W, Hünlich M, Baldus S, et al. Acute outcomes after MitraClip therapy in highly aged patients: results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry. EuroIntervention 2013;9:84-90.
18. Grayburn PA, Foster E, Sangli C, et al. Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation 2013;128:1667-74.
19. Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation following transcatheter mitral valve repair. J Am Coll Cardiol 2014;64: 182-92.
20. Sénéchal M, MacHaalany J, Bertrand OF, et al. Predictors of left ventricular remodeling after surgical repair or replacement for pure severe mitral regurgitation caused by leaflet prolapse. Am J Cardiol 2013;112:567-73.
21. Gaemperli O, Biaggi P, Gugelmann R, et al. Real-time left ventricular pressure-volume loops during percutaneous mitral valve repair with the MitraClip system. Circulation 2013;127:1018-27.
22. Alegria-Barrero E, Chan PH, Foin N, et al. Concept of the central clip: when to use one or two MitraClips. EuroIntervention 2014;9: 1217-24.
23. Mealing S, Feldman T, Eaton J, Singh M, Scott DA. EVEREST II high risk study based UK cost-effectiveness analysis of MitraClip in patients with severe mitral regurgitation ineligible for conventional repair/replacement surgery. J Med Econ 2013;16:1317-26.
24. Rosenhek R. Reverse remodeling in the perspective of decision making for mitral valve repair with the MitraClip. Circulation 2013;128: 1600-1.